AbCellera Biologics Inc.

ABCL

$11.57

+1.85%

N/A+$0.21

Healthcare

Biotechnology

NASDAQ

Active Trading

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes ...

Financial Highlights of ABCL

Profitability trend

Latest / TTM · 6 periods

Gross Margin

75.0%

Net Margin

-248.8%

P/E Ratio

-21.43x

n/a

Debt / Equity

0.15

n/a

Current Ratio

12.77

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

75.0%

Net Margin

-248.8%

P/E Ratio

-21.43x

Debt / Equity

0.15

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	87.9%	86.3%	100.0%	100.0%	61.6%	—
Operating MarginOperating income as a percentage of revenue.	54.5%	44.6%	-623.8%	-1091.7%	-289.0%	—
Net MarginNet income as a percentage of revenue.	40.9%	32.7%	-385.0%	-564.8%	-194.9%	—
EBITDA MarginEBITDA divided by revenue.	63.7%	53.6%	-505.3%	-708.0%	-198.0%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	58.4%	49.3%	-457.7%	-695.0%	-236.4%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	7.70	8.67	7.33	9.81	11.32	—
Quick RatioLiquid assets divided by current liabilities.	7.69	8.65	7.32	9.81	11.23	—
Cash RatioCash and equivalents divided by current liabilities.	3.95	3.27	1.12	2.04	2.00	—
Debt / AssetsDebt as a share of total assets.	3.0%	5.3%	5.2%	4.8%	10.6%	—
Debt / EquityDebt compared with shareholder equity.	0.04	0.07	0.07	0.06	0.15	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	2.15x	4.69x	0.59x	0.31x	0.49x	—
Inventory TurnoverHow often inventory is sold in a year.	27.22x	43.37x	0.00x	0.00x	4.55x	—
Payables TurnoverHow often payables are paid in a year.	3.05x	4.48x	0.00x	0.00x	1.14x	—
Asset TurnoverRevenue generated per dollar of assets.	0.28x	0.32x	0.03x	0.02x	0.06x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.49x	0.57x	0.05x	0.04x	0.11x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	25.54x	18.09x	-11.20x	-5.33x	-6.98x	—
P/B RatioPrice paid for each dollar of book value.	3.84x	2.34x	1.43x	0.82x	1.06x	—
P/S RatioPrice paid for each dollar of sales.	10.51x	5.95x	43.42x	29.91x	13.60x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	21.19x	14.11x	-13.60x	-4.61x	-5.87x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer